RW Monitor
10/16/2015
IN THE INDUSTRY
AREVA TN announced this week that Christopher Miller has joined the company as the new vice president for sales and marketing. Mille previously served as business development lead for AREVA Federal Services. “We are pleased to add Chris to our dynamic sales and marketing team,” AREVA TN Senior Vice President Greg Vesey said in a statement. “His role is critical to our continuing ability to listen to our customers, and provide them with cost and schedule certainty that drives successful long-term used fuel management programs. His experience at AFS will be invaluable as transportation and consolidated interim storage programs become even more critical to solving the used fuel challenge in America.” Miller replaces Jeff Isakson, who has been named director for the back-end business line.
Amec Foster Wheeler announced this week that it has been awarded a contract to study radioactive waste management at the Fukushima Daiichi cleanup. The study, according to a release from the engineer and project management specialist, will identify “practical planning tools to support the future development of a waste management strategy for the [Nuclear Damage Compensation and Decommissioning Facilitation Corporation (NDF)] at Fukushima, design case studies to demonstrate how the tools can be applied to deliver the best practicable environmental option for dealing with radioactive waste, and run workshops based on these case studies to provide NDF staff with hands-on, practical training.” Amec Foster Wheeler Clean Energy business President Clive White said the company brings “a thorough understanding of how to deal with radioactive waste so that the health of the public and site workers is protected.”
SHINE Medical Technologies and Savannah River Nuclear Solutions, the operating contractor for the Department of Energy’s Savannah River National Laboratory (SRNL), announced this week an agreement to allow an exclusive license on SRNL’s patented hydrogen isotope separation process for use in SHINE’s medical isotope production. According to a release, the agreement gives SHINE the right to use SRNL’s thermal cycling absorption process (TCAP) in its manufacturing facility. The TCAP provides the high-purity inputs needed for SHINE’s patented technology, which enhances the production of medical isotopes, including molybdenum-99. “We are extremely pleased to have the opportunity to contribute to solving the global problem of medical isotope shortages. SHINE’s isotope manufacturing plant will be a game-changer for U.S. patients and we’re proud to be part of making that happen,” SRNL Director Terry Michalske said in a statement. SHINE CEO Greg Piefer added, “Savannah River National Laboratory has put a tremendous amount of effort into developing and refining the TCAP technology and we’re excited to take advantage of this proven, state-of-the-art technology in our facility.”
